Related Experiment Video
Updated: Jun 26, 2025
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.8K
Mixed histiocytic disorders: Nature versus nurture?
Kenneth McClain1, Peter Dimitrion2
1Baylor College of Medicine, Texas Children's Cancer and Hematology Centers, Houston, Texas, USA.
British Journal of Haematology
|May 19, 2024
Summary
Histiocytic diseases stem from MAPK mutations in myeloid cells. These mutations lead to distinct conditions like Langerhans cell histiocytosis or Erdheim-Chester disease based on cell lineage.
Area of Science:
- Oncology
- Hematology
- Genetics
Background:
- Histiocytic diseases are a group of rare disorders originating from myeloid progenitor cells.
- These conditions are characterized by abnormal proliferation of histiocytes, a type of immune cell.
- Somatic mutations, particularly in the MAPK pathway, are implicated in the pathogenesis of these diseases.
Purpose of the Study:
- To analyze a multicenter series of mixed histiocytic neoplasms.
- To identify diverse somatic mutations driving these neoplasms.
- To evaluate patient responses to targeted therapies.
Main Methods:
- Retrospective analysis of a multicenter cohort of patients with histiocytic neoplasms.
- Comprehensive genomic profiling to identify somatic mutations.
- Clinical data review to assess treatment responses to targeted therapies.
Main Results:
- Diverse somatic mutations were identified across various histiocytic neoplasms.
- Specific mutations correlated with distinct histopathological subtypes.
- Some patients showed promising responses to targeted therapies directed at identified mutations.
Conclusions:
- Histiocytic diseases exhibit significant molecular heterogeneity.
- Targeted therapies hold potential for treating specific subsets of histiocytic neoplasms.
- Further research is warranted to elucidate the full spectrum of mutations and optimize treatment strategies.
